Mereo BioPharma Group Plc (MREO)
0.3798
+0.01
(+3.52%)
USD |
NASDAQ |
Oct 02, 16:00
0.3726
-0.01
(-1.90%)
After-Hours: 20:00
Mereo BioPharma Group Enterprise Value : 31.54M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 31.54M |
| October 01, 2026 | 29.48M |
| September 30, 2026 | 35.08M |
| September 29, 2026 | 30.48M |
| September 28, 2026 | 29.97M |
| September 25, 2026 | 29.97M |
| September 24, 2026 | 24.78M |
| September 23, 2026 | 25.23M |
| September 22, 2026 | 21.40M |
| September 21, 2026 | 17.22M |
| September 18, 2026 | 19.28M |
| September 17, 2026 | 17.22M |
| September 16, 2026 | 13.37M |
| September 15, 2026 | 16.40M |
| September 14, 2026 | 15.61M |
| September 11, 2026 | 15.61M |
| September 10, 2026 | 9.955M |
| September 09, 2026 | 9.620M |
| September 08, 2026 | 11.55M |
| September 04, 2026 | 10.82M |
| September 03, 2026 | 14.36M |
| September 02, 2026 | 13.56M |
| September 01, 2026 | 15.08M |
| August 31, 2026 | 13.50M |
| August 28, 2026 | 11.22M |
| Date | Value |
|---|---|
| August 27, 2026 | 14.33M |
| August 26, 2026 | 15.29M |
| August 25, 2026 | 15.86M |
| August 24, 2026 | 17.12M |
| August 21, 2026 | 17.27M |
| August 20, 2026 | 17.73M |
| August 19, 2026 | 20.63M |
| August 18, 2026 | 20.87M |
| August 17, 2026 | 20.03M |
| August 14, 2026 | 21.81M |
| August 13, 2026 | 20.03M |
| August 12, 2026 | 19.26M |
| August 11, 2026 | 19.68M |
| August 10, 2026 | 14.39M |
| August 07, 2026 | 18.21M |
| August 06, 2026 | 19.74M |
| August 05, 2026 | 19.36M |
| August 04, 2026 | 22.33M |
| August 03, 2026 | 21.27M |
| July 31, 2026 | 25.61M |
| July 30, 2026 | 21.19M |
| July 29, 2026 | 19.84M |
| July 28, 2026 | 20.30M |
| July 27, 2026 | 19.13M |
| July 24, 2026 | 16.85M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -20.30M |
| BioNTech SE | 7.809B |
| Silence Therapeutics Plc | 495.01M |
| Autolus Therapeutics Plc | 638.46M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.018M |
| Total Expenses (Quarterly) | 7.018M |
| EPS Diluted (Quarterly) | -0.0437 |
| Earnings Yield | -46.13% |
| Normalized Earnings Yield | -46.74 |